---
title: "SAB BIO Reports Q1 2026 Financial Results and Recent Business Highlights"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286092732.md"
description: "Enrollment for the registrational SAFEGUARD trial of SAB-142 is ongoing with site activation continuing. The trial is expected to be completed by the end of 2026. Topline data from the trial is anticipated to be available in the second half of 2027."
datetime: "2026-05-12T11:31:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286092732.md)
  - [en](https://longbridge.com/en/news/286092732.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286092732.md)
---

# SAB BIO Reports Q1 2026 Financial Results and Recent Business Highlights

Enrollment for the registrational SAFEGUARD trial of SAB-142 is ongoing with site activation continuing. The trial is expected to be completed by the end of 2026. Topline data from the trial is anticipated to be available in the second half of 2027.

### Related Stocks

- [SABS.US](https://longbridge.com/en/quote/SABS.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [SABSW.US](https://longbridge.com/en/quote/SABSW.US.md)

## Related News & Research

- [HEDGE FLOW-Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman says](https://longbridge.com/en/news/293938581.md)
- [Wall Street warms to healthcare stocks as tech trade faces turbulence](https://longbridge.com/en/news/294948951.md)
- [Medicare is about to change a drug program that held down the cost of premiums. Here's what to know.](https://longbridge.com/en/news/294391519.md)
- [Full Transcript: SAB Biotherapeutics Q1 2026 Earnings Call](https://longbridge.com/en/news/286105754.md)
- [Trump Says US To Exempt Import Tariff On Generic Drugs For Two Years](https://longbridge.com/en/news/293481843.md)